SUSANNAH GREEN: Open Payments
NPI 1992198550 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 37 payments from 16 companies in 2025. Trend: 2023 $241 · 2024 $422 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $123 |
| ABBVIE INC. | 5 | $94 |
| Amgen Inc. | 4 | $73 |
| PFIZER INC. | 4 | $63 |
| Abbott Laboratories | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Insulet Corporation | 1 | $23 |
Products named: MOUNJARO, UBRELVY, JARDIANCE, NURTEC ODT, FREESTYLE LIBRE 3, OTEZLA, Veozah, STRENSIQ.
Industry payments across MO — which companies pay providers there.
